Policy

For psychiatrist David A. Hamburg, an early interest in biobehavioral aspects of stress and aggression has broadened to embrace many issues in education, health and public policy. After brief stints at Walter Reed Army Institute of Medical Research and as chief of the adult psychiatry branch at the National Institute of Mental Health, he established the psychiatry department at Stanford University's medical school in 1961. Hamburg left Stan-ford in 1975 to become president of the Institute of Me

| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Since 1983, Hamburg has been president of the Carnegie Corporation, whose philanthropic work traditionally has focused on education and social justice. Under his leadership, the foundation now also addresses such problems as teenage pregnancy and the avoidance of nuclear war. Hamburg has urged universities to study the causes and prevention of violence, including terrorism. His interest in that subject is partly personal: In 1975, he spent 10 weeks in Zaire successfully negotiating the release of four Stanford students who had been taken captive by guerrillas.

Hamburg, who served as president of the American Association for the Advancement of Science in 1984-85, was interviewed in his Manhattan office January 29 by Tabitha M. Powledge, editor of The Scientist. This is an edited version of their talk.

Carnegie is supporting Admiral Stansfield Turner, the former head of the CIA, who's doing a book with an academic colleague that looks at a series ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies